![Pamela Bowe Morris](https://www.triglycerideforum.org/wp-content/uploads/2024/02/Bowe-Morris-150x150.jpg)
Therapeutic options for the severely hypertriglyceridaemic patient: Now and in the future
Dr Pamela Bowe MorrisWatch the presentation >
![Sam Tsimikas](https://www.triglycerideforum.org/wp-content/uploads/2024/03/Tsimikas-150x150.jpg)
ApoC3 as a therapeutic target for treatment of severe hypertriglyceridaemia
(ii) Olezarsen
Professor Sam Tsimikas
Watch the presentation >
![Daniel Gaudet](https://www.triglycerideforum.org/wp-content/uploads/2023/12/Gaudet-sq-150x150.jpg)
ApoC3 as a therapeutic target for treatment of severe hypertriglyceridaemia
(i) Plozasiran
Professor Daniel Gaudet
Watch the presentation >
![Michael Ploug](https://www.triglycerideforum.org/wp-content/uploads/2024/02/Ploug-150x150.jpg)
Molecular insights into lipolysis
Michael PlougWatch the presentation >
![Rob Hegele](https://www.triglycerideforum.org/wp-content/uploads/2020/12/Hegele-final-150x150.jpg)
KEYNOTE: Genetics of familial chylomicronaemia syndrome (FCS) and severe hypertriglyceridaemia
Professor Robert A HegeleWatch the presentation >
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
![Arrowhead Pharmaceuticals](https://www.triglycerideforum.org/wp-content/uploads/2023/10/arrowhead_logo.png)
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
![Ionis Logo](https://www.triglycerideforum.org/wp-content/uploads/2021/08/IonisLogo.png)
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
![Kowa Logo](https://www.triglycerideforum.org/wp-content/uploads/2020/11/kowaEnglish_mark.jpg)